Pre-market Hot Trades in US Stocks
BGM is down 12.59% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 14, BGM Group submitted an initial Form 3 filing regarding director Lou Zefei in the EDGAR system. This move may raise market concerns about the company's governance structure, leading to stock price volatility.
</li>
<li>
On May 14, BGM Group reported the initial Form 3 filing for Ren Yuehua as a director. This information may affect investor confidence in the company's management, further exacerbating the stock price decline.
</li>
<li>
On May 14, BGM Group submitted an initial Form 3 filing regarding Chief Financial Officer Zhai Yaxuan. This move may raise market concerns about the company's financial management, putting pressure on the stock price. There is increased market attention on the company's governance structure.
</li>
</ol>
Dominion Energy is up 11.78% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 18, NextEra Energy Group plans to acquire Dominion Energy at approximately $76 per share, driving the stock price up 12.4% in pre-market trading. This news has sparked positive market expectations for the merger, boosting Dominion Energy's stock price.
</li>
<li>
On May 16, Zhitong Finance reported that NextEra is in talks to merge with Dominion Energy, with the transaction primarily taking place in stock. This news has raised market expectations for potential growth following the merger of the two companies, driving up Dominion Energy's stock price.
</li>
<li>
On May 18, the market anticipates that the Federal Reserve may raise interest rates, which could put pressure on the utility sector. However, the growing demand for power in data centers provides a new growth narrative for Dominion Energy. The utility sector is generally performing weakly, with attention on interest rate hike expectations.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Sunshine Biopharma is up 154.63% in pre-market trading, with no significant recent news. Trading is active, and there is a clear flow of funds. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
NextNRG is up 94.01% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 15, NextNRG announced a conference call on May 18 to discuss its financial performance for the first quarter of 2026 and company updates. This move shows the company's commitment to transparency and investor communication, driving the stock price up.
</li>
<li>
On May 16, NextNRG reported a 29% revenue growth in the last fiscal year, reaching $21.1 million, while gross profit significantly increased, and interest expenses decreased by 80%. These financial achievements have boosted market confidence, promoting the stock price rise.
</li>
<li>
On May 16, analyst Amit Dayal gave NextNRG a &#34;Buy&#34; rating with a target price of $5, indicating a potential upside of 1683%. This rating has enhanced investor expectations for the company's future performance, further driving the stock price up. The energy sector has performed strongly recently, with noticeable fund inflows
Picard Medical pre-market rose 78%. Based on recent key news:
</li>
<li>
On May 15, Picard Medical released its financial report showing a year-on-year revenue increase of 85% to $1.15 million, but net losses widened to $7.6 million, mainly due to increased R&amp;D and legal expenses. The company received a non-compliance notice from the New York Stock Exchange and is seeking additional funding to support operations. This news attracted market attention and drove the stock price up.
</li>
<li>
On May 15, the company increased its investment in R&amp;D and production, particularly significantly increasing R&amp;D activities for the next-generation Emperor TAH device. Management is focused on scaling up production and commercializing in the U.S. market to absorb fixed costs. These positive operational strategies have boosted investor confidence, further driving the stock price up.
</li>
<li>
On May 15, the company announced the successful implantation of 100 devices in 27 countries, demonstrating its potential for global market expansion. This international progress supports the company's future growth and attracts more investor attention. The medical device industry has performed strongly recently, with significant capital inflows
</li>
</ol>

BGM pre-market down 12.59%; Dominion Energy pre-market up 11.78%; Sunshine Biopharma pre-market up 154.63%; NextNRG pre-market up 94.01%; Picard Medical pre-market up 78.00%

Price Alert

Pre-market hot trades in US stocks: BGM pre-market down 12.59%; Dominion Energy pre-market up 11.78%